Parry-Romberg syndrome in a patient with scleroderma

BMJ Case Rep. 2018 Nov 14:2018:bcr2018226754. doi: 10.1136/bcr-2018-226754.

Abstract

Parry-Romberg syndrome (PRS) is characterised by progressive but self-limiting facial hemiatrophy. We describe a 48-year-old woman with a 3-year history of gradually worsening right facial hemiatrophy on a background of scleroderma. Her initial primary concern was alopecia. Within the last year, there was greater prominence of her right zygoma and hyperpigmentation on her forearms and left neck. She also had worsening headaches and neck stiffness in the mornings. A clinical diagnosis of PRS was made and she was subsequently treated with a course of methotrexate. She is due to be followed up by dermatology, rheumatology and maxillofacial surgery with the aim of reconstructive surgery once her symptoms stabilise.

Keywords: connective tissue disease; dermatology.

Publication types

  • Case Reports

MeSH terms

  • Dermatologic Agents / therapeutic use
  • Facial Hemiatrophy / complications*
  • Female
  • Humans
  • Methotrexate / therapeutic use
  • Middle Aged
  • Scleroderma, Localized / complications*
  • Scleroderma, Localized / drug therapy

Substances

  • Dermatologic Agents
  • Methotrexate